Matches in SemOpenAlex for { <https://semopenalex.org/work/W2401368754> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2401368754 abstract "Antibodies that block the PD-1/PD-L1 pathway have demonstrated therapeutic success against several cancer types, but do not induce a response in the majority of patients. The development of treatments that provide activation signals to T cells by targeting co-stimulatory receptors, in addition to checkpoint inhibition, may increase anti-tumor immunity and the percent of responding patients. CD80/B7-1 is a co-stimulatory molecule that also interacts with PD-L1. CD80 is expressed by antigen presenting cells and ligates to CD28 providing co-stimulation during T cell activation. Furthermore, PD-L1 interacts with T cell CD80 in a reverse signaling pathway that promotes T cell anergy. The ability of CD80 to block inhibitory and promote stimulatory signaling pathways in T cell activation suggests potential therapeutic value. We have shown that soluble CD80 fused to the Fc region of IgG (CD80-Fc) blocks PD-1/PD-L1 interactions thus restoring activation of CD4+ and CD8+ T cells. Moreover, CD80-Fc was more effective in vitro than PD-1/PD-L1 monoclonal antibodies at restoring T cell activation, which suggests that CD80-Fc may be stimulating CD28 in addition to blocking PD-1/PD-L1 signaling. Stimulation of T cell CD28 in the absence of other signals induces downstream transcription, and signaling pathway activation. In fact, agonist CD28 antibody can induce functions in T cells in both naive and activated cells, even in the absence of TCR activation. We now demonstrate that CD80-Fc does indeed stimulate T cells via CD28 activation by demonstrating comparable downstream results of CD80-Fc and agonist CD28 antibody treatment of both human and mouse T cells. Therefore, CD80-Fc may provide a novel therapeutic approach to target T cell checkpoint inhibition in addition to providing stimulatory signaling to improve T cell activation and anti-tumor immunity. Citation Format: Tiha M. Long, Suzanne Ostrand-Rosenberg. A soluble form of CD80 inhibits PD-L1 immune suppression and stimulates T cells through CD28-specific pathways indicating potential for increased therapeutic activity over checkpoint inhibition alone. [abstract]. In: Proceedings of the CRI-CIMT-EATI-AACR Inaugural International Cancer Immunotherapy Conference: Translating Science into Survival; September 16-19, 2015; New York, NY. Philadelphia (PA): AACR; Cancer Immunol Res 2016;4(1 Suppl):Abstract nr B017." @default.
- W2401368754 created "2016-06-24" @default.
- W2401368754 creator A5022466116 @default.
- W2401368754 creator A5059743119 @default.
- W2401368754 date "2016-01-01" @default.
- W2401368754 modified "2023-09-27" @default.
- W2401368754 title "Abstract B017: A soluble form of CD80 inhibits PD-L1 immune suppression and stimulates T cells through CD28-specific pathways indicating potential for increased therapeutic activity over checkpoint inhibition alone" @default.
- W2401368754 doi "https://doi.org/10.1158/2326-6074.cricimteatiaacr15-b017" @default.
- W2401368754 hasPublicationYear "2016" @default.
- W2401368754 type Work @default.
- W2401368754 sameAs 2401368754 @default.
- W2401368754 citedByCount "0" @default.
- W2401368754 crossrefType "proceedings-article" @default.
- W2401368754 hasAuthorship W2401368754A5022466116 @default.
- W2401368754 hasAuthorship W2401368754A5059743119 @default.
- W2401368754 hasConcept C148125776 @default.
- W2401368754 hasConcept C153911025 @default.
- W2401368754 hasConcept C154317977 @default.
- W2401368754 hasConcept C185592680 @default.
- W2401368754 hasConcept C202751555 @default.
- W2401368754 hasConcept C203014093 @default.
- W2401368754 hasConcept C2776090121 @default.
- W2401368754 hasConcept C2778297628 @default.
- W2401368754 hasConcept C2780405999 @default.
- W2401368754 hasConcept C2781101188 @default.
- W2401368754 hasConcept C39347974 @default.
- W2401368754 hasConcept C502942594 @default.
- W2401368754 hasConcept C55493867 @default.
- W2401368754 hasConcept C62478195 @default.
- W2401368754 hasConcept C67662055 @default.
- W2401368754 hasConcept C86803240 @default.
- W2401368754 hasConcept C8891405 @default.
- W2401368754 hasConcept C95444343 @default.
- W2401368754 hasConceptScore W2401368754C148125776 @default.
- W2401368754 hasConceptScore W2401368754C153911025 @default.
- W2401368754 hasConceptScore W2401368754C154317977 @default.
- W2401368754 hasConceptScore W2401368754C185592680 @default.
- W2401368754 hasConceptScore W2401368754C202751555 @default.
- W2401368754 hasConceptScore W2401368754C203014093 @default.
- W2401368754 hasConceptScore W2401368754C2776090121 @default.
- W2401368754 hasConceptScore W2401368754C2778297628 @default.
- W2401368754 hasConceptScore W2401368754C2780405999 @default.
- W2401368754 hasConceptScore W2401368754C2781101188 @default.
- W2401368754 hasConceptScore W2401368754C39347974 @default.
- W2401368754 hasConceptScore W2401368754C502942594 @default.
- W2401368754 hasConceptScore W2401368754C55493867 @default.
- W2401368754 hasConceptScore W2401368754C62478195 @default.
- W2401368754 hasConceptScore W2401368754C67662055 @default.
- W2401368754 hasConceptScore W2401368754C86803240 @default.
- W2401368754 hasConceptScore W2401368754C8891405 @default.
- W2401368754 hasConceptScore W2401368754C95444343 @default.
- W2401368754 hasLocation W24013687541 @default.
- W2401368754 hasOpenAccess W2401368754 @default.
- W2401368754 hasPrimaryLocation W24013687541 @default.
- W2401368754 hasRelatedWork W1645848851 @default.
- W2401368754 hasRelatedWork W1879292914 @default.
- W2401368754 hasRelatedWork W1975290019 @default.
- W2401368754 hasRelatedWork W1983048873 @default.
- W2401368754 hasRelatedWork W2016819838 @default.
- W2401368754 hasRelatedWork W2067633711 @default.
- W2401368754 hasRelatedWork W2282790147 @default.
- W2401368754 hasRelatedWork W2334001335 @default.
- W2401368754 hasRelatedWork W2378501241 @default.
- W2401368754 hasRelatedWork W2590742132 @default.
- W2401368754 hasRelatedWork W2592915108 @default.
- W2401368754 hasRelatedWork W2739817841 @default.
- W2401368754 hasRelatedWork W2767593553 @default.
- W2401368754 hasRelatedWork W2896120245 @default.
- W2401368754 hasRelatedWork W2899058237 @default.
- W2401368754 hasRelatedWork W2926473910 @default.
- W2401368754 hasRelatedWork W2952174619 @default.
- W2401368754 hasRelatedWork W3006007810 @default.
- W2401368754 hasRelatedWork W3211956859 @default.
- W2401368754 hasRelatedWork W998207682 @default.
- W2401368754 isParatext "false" @default.
- W2401368754 isRetracted "false" @default.
- W2401368754 magId "2401368754" @default.
- W2401368754 workType "article" @default.